Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
Feb 26, 16:00
Hansa Biopharma Profit Margin (Quarterly) : -217.2% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Orexo AB | -- |
| BioInvent International AB | -3.89K% |
| BioArctic AB | -4.80% |
| BioGaia AB | 22.42% |
| Camurus AB | 21.72% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -63.22% |
| Return on Invested Capital | -104.7% |
| Gross Profit Margin (Quarterly) | 67.55% |
| Operating Margin (Quarterly) | -164.1% |
| Return on Net Operating Assets | -135.9% |